Xenon Pharmaceuticals (XENE) Shares Outstanding (2013 - 2026)

Xenon Pharmaceuticals (XENE) Shares Outstanding (2013 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 6,012.74 Bn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 47.82 Bn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.44 Bn
4 NuCana 279.75 Bn 279.75 Bn - 11.23 Bn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 254.10 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 104.00 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - 400.00 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 62.19 Mn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 198.10 Mn
10 Xenon Pharmaceuticals 5.71 Bn 5.71 Bn - 87.35 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 87.35 Mn
Dec 31, 2025 79.25 Mn
Sep 30, 2025 79.25 Mn
Jun 30, 2025 78.95 Mn
Mar 31, 2025 78.69 Mn
Dec 31, 2024 77.89 Mn
Sep 30, 2024 77.93 Mn
Jun 30, 2024 77.67 Mn
Mar 31, 2024 77.59 Mn
Dec 31, 2023 66.89 Mn
Sep 30, 2023 66.00 Mn
Jun 30, 2023 65.86 Mn
Mar 31, 2023 65.72 Mn
Dec 31, 2022 60.54 Mn
Sep 30, 2022 65.47 Mn
Jun 30, 2022 56.19 Mn
Mar 31, 2022 54.85 Mn
Dec 31, 2021 43.63 Mn
Sep 30, 2021 41.19 Mn
Jun 30, 2021 43.11 Mn